氨酸干预诱导PD-L1表达,以增强MTAP删除骨髓瘤的免疫检查点治疗反应
Haoran Mu1, Qi Zhang2, Dongqing Zuo1
1Department of Orthopedic Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Bone Tumor Institution, Shanghai, China.
Cell reports. Medicine
|February 21, 2025
概括
带有MTAP删除的骨髓瘤抵抗免疫疗法. 在临床前模型中,通过改变新陈代谢,氨酸干预增强了免疫反应和ICT疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢研究研究 代谢研究
背景情况:
- 骨髓瘤 (OS) 是一种骨癌,结果不佳,对免疫检查点治疗 (ICT) 的反应较低.
- 有甲基腺酸酶 (MTAP) 缺失的OS子组表现出对ICT的抗性,其特征是"冷"的瘤微环境.
研究的目的:
- 调查MTAP删除在OS免疫逃避中的作用.
- 在MTAP删除的OS中探索 metionin代谢作为治疗点.
- 在临床前的OS模型中评估 metionin干预和ICT的组合.
主要方法:
- 基因组学和转录组学分析以确定OS子组.
- 在MTAP删除的OS的体外和体外模型.
- 评估氨酸代谢,PD-L1表达,免疫细胞透和生存.
主要成果:
- 在OS中MTAP删除与ICT耐药性和"冷"瘤微环境有关.
- 氨酸代谢是MTAP删除的OS中的一个关键漏洞.
- 氨酸干预 (饮食限制或MAT2A抑制) 通过IKZF1.1提高PD-L1的调节.
- metionin 的干预增强了免疫信号和 CD8+ T 细胞的透.
- 组合疗法在小鼠模型中显著改善了生存率.
结论:
- 通过代谢变化,MTAP的删除使骨髓瘤通过代谢变化产生免疫抵抗.
- 准 metionin代谢是一种有希望的策略,可以使MTAP删除的操作系统对ICT敏感.
- 氨酸干预和ICT的结合显示了这一OS亚组的显著治疗潜力.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


